Journal of Histochemistry and Cytochemistry, Vol. 49, 1341-1350, November 2001, Copyright © 2001, The Histochemical Society, Inc.


ARTICLE

Increased Expression of Tenascin-C-binding Epithelial Integrins in Human Bullous Keratopathy Corneas

Alexander V. Ljubimova, Mehrnoosh Saghizadeha, Robert Pytelab, Dean Sheppardb, and M. Cristina Kenneya
a Ophthalmology Research Laboratories, Burns & Allen Research Institute, Cedars–Sinai Medical Center, University of California Los Angeles School of Medicine Affiliate, Los Angeles, California
b Department of Medicine and Lung Biology Center/San Francisco General Hospital, University of California San Francisco, San Francisco, California

Correspondence to: Alexander V. Ljubimov, Ophthalmology Research Laboratories, Cedars–Sinai Medical Center, 8700 Beverly Boulevard, Davis-5069, Los Angeles, CA 90048. E-mail: ljubimov@cshs.org


  Summary
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

We previously found an abnormal deposition of an extracellular matrix glycoprotein, tenascin-C (TN-C), in human corneas with pseudophakic/aphakic bullous keratopathy (PBK/ABK). In this work, we studied cellular TN-C receptors in normal and PBK/ABK corneas. Cryostat sections of normal and PBK/ABK corneas were stained by immuno-fluorescence for TN-C receptors: {alpha}2, {alpha}8, {alpha}9, {alpha}Vß3, ß1, and ß6 integrins, and annexin II. ß6 integrin mRNA levels were assessed by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) using ß2-microglobulin gene to normalize the samples. In PBK/ABK compared to normal corneas, relatively minor changes were observed for {alpha}2 and ß1 integrins, and for annexin II. {alpha}8, {alpha}9, and ß6 subunits of TN-C receptors, {alpha}8ß1 {alpha}9ß1, and {alpha}Vß6, respectively, were absent from normal central corneas but were found in the central epithelium of PBK/ABK corneas. ß6 integrin showed the most significant accumulation. It correlated best with the expression of TN-C rather than with the expression of other {alpha}Vß6 ligands, fibronectin, and vitronectin. RT-PCR analysis also showed elevated levels of ß6 mRNA in PBK/ABK compared to normal corneas. Therefore, accumulation of TN-C in PBK/ABK corneas was accompanied by an increased expression of its three binding integrins, especially {alpha}Vß6 in the corneal epithelium. The interaction of tenascin-C with these integrins may contribute to the fibrotic process that occurs in PBK/ABK corneas.

(J Histochem Cytochem 49:1341–1350, 2001)

Key Words: bullous keratopathy, corneal epithelium, tenascin-C, {alpha}Vß6 integrin, {alpha}8 integrin, {alpha}9 integrin, annexin II, RT-PCR, immunofluorescence


  Introduction
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

PSEUDOPHAKIC (PBK) and aphakic (ABK) bullous keratopathy is a common blistering corneal disease and is the leading indication for corneal transplantation and regraft (Dobbins et al. 2000 ; Maeno et al. 2000 ; Patel et al. 2000 ). These two disorders are both consequences of cataract surgery and differ from each other only by the presence (PBK) or absence (ABK) of an artificial intraocular lens. Because the histopathological features of PBK and ABK are the same, we will not categorize them separately. Typical signs of PBK/ABK include endothelial cell dysfunction and loss, progressing corneal edema with loss of transparency, formation of fluid-filled subepithelial bullae (blisters), and development of subepithelial fibrosis and a posterior collagenous layer/retrocorneal fibrous membrane (Kay et al. 1982 ; Waring 1982 ; Sasaki et al. 1986 ; McCartney et al. 1987 ; Kenney and Chwa 1990 ; Liu et al. 1993 ; Numa et al. 1993 ; Ljubimov et al. 1996 ).

We have previously shown that PBK/ABK corneas presented signs of an ongoing fibrotic process characterized by excessive deposition of specific extracellular matrix (ECM) components (Ljubimov et al. 1996 , Ljubimov et al. 1998b , Ljubimov et al. 1998c ). The most conspicuous changes concerned an ECM glycoprotein, tenascin-C (TN-C). Unlike normal corneas, in which it was present only in the limbus, TN-C was deposited in the stroma and basement membranes (BMs) of central PBK/ABK corneas with a respective increase of mRNA levels (Ljubimov et al. 1996 , Ljubimov et al. 1998b ). Smaller splice variants of TN-C were mostly found in PBK/ABK corneas (Ljubimov et al. 1998b ; Saghizadeh et al. 1998 ).

TN-C may be adhesive for some cell types and antiadhesive for others (Mackie 1997 ; Vollmer 1997 ; Jones and Jones 2000 ; Orend and Chiquet-Ehrismann 2000 ). It has a number of splice variants that may differentially affect cell migration, proliferation, and neurite outgrowth (Murphy-Ullrich et al. 1991 ; Leprini et al. 1994 ; Meiners and Geller 1997 ; Ljubimov et al. 1998b ; Joester and Faissner 1999 ; Meiners et al. 1999 ). TN-C has binding sites for various cell surface receptors that mediate its interactions with cells (Jones and Jones 2000 ). Except for annexin II (Chung and Erickson 1994 ), these receptors belong to the integrin family of heterodimer cell surface receptors and include {alpha}2ß1, {alpha}8ß1 {alpha}9ß1, {alpha}Vß3, and {alpha}Vß6 (Joshi et al. 1993 ; Prieto et al. 1993 ; Sriramarao et al. 1993 ; Schnapp et al. 1995b ; Yokosaki et al. 1996 ; Jones and Jones 2000 ). We hypothesized that elevated expression of TN-C in PBK/ABK corneas would be accompanied by a concomitant increase in its specific receptors. To explore this possibility, we have studied the expression of all known TN-C receptors in normal and PBK/ABK corneas by immunofluorescence. The results show that several epithelial TN-C-binding integrins ({alpha}8ß1, {alpha}9ß1, {alpha}Vß6) appeared in PBK/ABK corneas. Of these integrins, {alpha}Vß6 integrin showed the most significant correlation with TN-C overexpression.


  Materials and Methods
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Tissue
A total of 15 normal and 38 age-matched PBK/ABK corneas were used. Diseased corneas removed during corneal transplantation were received from local collaborating surgeons. Tissue collection was conducted under the Cedars–Sinai Medical Center IRB protocol number 3201. Normal autopsy corneas were received from the National Disease Research Interchange (Philadelphia, PA), which has a human tissue collection protocol approved by a managerial committee and subject to National Institutes of Health oversight. All tissues were processed within 30 hr after death or corneal transplantation. For PBK/ABK corneas, only a central part was available that had been removed during transplantation. Because of this, all ECM abnormalities in PBK/ABK corneas were previously documented in the central part only, where Bowman's layer lies underneath the epithelium (Ljubimov et al. 1996 ). Therefore, for gene expression study by RT-PCR, normal corneas were trephined before freezing and central parts only (without limbus) were analyzed to ensure adequate comparison between groups. In immunostaining experiments, again, only central parts of normal and PBK/ABK corneas were compared. Because of the small amount of material available from a single cornea, immunohistochemical and RT-PCR studies were performed with different sets of normal and PBK/ABK corneas.

Immunohistochemistry
Corneas (10 normal and 26 age-matched PBK/ABK) were bisected and embedded in OCT compound (Ted Pella; Redding, CA). Six-µm cryostat sections were prepared and stained by indirect immunofluorescence for ECM components and integrins, as previously described (Ljubimov et al. 1995 ). Routine specificity controls (without primary or secondary antibodies) were negative. Sections of normal and PBK/ABK corneas were exposed to the same dilutions of antibodies simultaneously. Hybridoma supernatants were used undiluted, and purified antibodies were used at 10–20 µg/ml. Well-characterized mouse monoclonal antibodies were used to total TN-C (clone BC8; Balza et al. 1993 ; a kind gift from Dr. L. Zardi, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy), total fibronectin (clone 568; Ljubimov et al. 1995 ), annexin II (clone 5; Transduction Laboratories, Lexington, KY), vitronectin (clone RM68), integrins {alpha}Vß3 (clone LM609), {alpha}3ß1 (clone M-KID 2), {alpha}1 I domain (clone FB12), {alpha}6 (clone NKI-GoH3), ß1 (clone HB1.1), ß4 (clone 3E1) (all from Chemicon International; Temecula, CA), and ß6 (clone E7P6; Weinacker et al. 1994 ). Rabbit polyclonal antibodies were used to TN-C and integrins {alpha}5ß1, {alpha}2 (all from Chemicon International), {alpha}8 (Schnapp et al. 1995a ), and {alpha}9 (Palmer et al. 1993 ; Sta Iglesia et al. 2000 ). Both antibodies to {alpha}9 reacted in an identical way. Cross-species adsorbed fluorescein- and rhodamine-conjugated secondary antibodies were from Chemicon International. In double-label experiments (not shown here), it was found that in PBK/ABK corneas, affinity-purified polyclonal antibody to TN-C (Chemicon International) reacted identically with the monoclonal antibody BC-8.

Semiquantitative RT-PCR
This was done as previously described (Ljubimov et al. 1998b ; Saghizadeh et al. 1998 ). Briefly, total RNA was isolated from five normal and 12 age-matched PBK/ABK corneas with TRIZOL (Invitrogen Life Technologies; Carlsbad, CA). cDNA samples were subjected to polymerase chain reaction (PCR) using specific primers for ß6 integrin and for ß2-microglobulin 2-MG) that served as a housekeeping gene for sample normalization. The primers for RT-PCR were the following: ß6 integrin forward, 5'-GTGAGATCA-ACATCAATGGAGC-3'; ß6 integrin reverse, 5'-TTACACAC-TCCTGGGAACACTTC-3'; product size 181 base pairs (bp); ß2-MG (Saghizadeh et al. 1998 ) forward, 5'-CTCGCGCT-ACTCTCTCTTTCTG-3'; ß2-MG reverse, 5'-GCTTACATGT-CTCGATCCCACTT-3', product size 335 bp.

PCR was carried out with 25 ng of reverse-transcribed RNA, using 1.25 U Taq polymerase (Invitrogen Life Technologies) and 2 mM Mg++. Each cycle consisted of 30-sec denaturation at 94C, 30-sec annealing at 65C, and 45-sec elongation at 72C. Samples normalized by ß2-MG amplification were amplified in a linear range established using serial cDNA dilutions and varying the number of cycles. A total of 33 cycles were used for ß6 integrin and 31 cycles for ß2-MG. Amplified products were separated by electrophoresis in 3% agarose gels and visualized under UV light after staining with ethidium bromide. Routine RT-PCR controls without reverse transcriptase were negative.

Southern blotting analysis was done as described previously (Ljubimov et al. 1998b ) using the following oligonucleotide probes: ß6 integrin, 5'-GGAAGCCCGTGCACCCT-ATGCCAAGTTGATCCCATAT-3'; ß2-MG (Saghizadeh et al. 1998 ), 5'-GTCTTTCAGCAAGGACTGGTCTTTCTATCT-CTTGTA-3'. Band densities were measured by scanning densitometry and the ratios of ß6 integrin to ß2-MG for each sample were determined.

Statistical Analysis
Immunostaining data were analyzed by the two-sided Fisher's exact test using InStat software program (GraphPad Software; San Diego, CA). To this end, the number of cases with abnormal staining pattern in one experimental group (e.g., normal) was compared to the number of cases with abnormal staining pattern in another experimental group (e.g., PBK/ABK). RT-PCR band relative intensities were compared by the two-tailed unpaired Student's t-test using the InStat program and were expressed as mean ± SEM. With both methods, p<0.05 was considered significant.


  Results
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Appearance of Tenascin-C-binding Integrins {alpha}8ß1, {alpha}9ß1, and {alpha}Vß6 in PBK/ABK corneas
Normal central corneal epithelial cells and keratocytes expressed the TN-C receptors {alpha}2ß1 integrin and annexin II, as determined by immunofluorescence (Fig 1). In the corneal epithelium, distinct basal cell surface staining was seen for both components. In central PBK/ABK corneas, these receptors were not changed in about half of cases. In the remaining cases (5/11), {alpha}2 integrin appeared reduced in the epithelium (Fig 1). In 6/11 PBK/ABK cases, more (Fig 1) or less staining than normal was observed for annexin II, especially at the basal surface of basal epithelial cells. The stromal staining for both these receptors did not change in diseased corneas. {alpha}Vß3 integrin was not found either in normal or in PBK/ABK corneas (Fig 1), in accordance with previous data (Tervo et al. 1991 ).



View larger version (111K):
[in this window]
[in a new window]
 
Figure 1. Select TN-C receptors in normal (N) and PBK/ABK corneas. {alpha}Vß3 integrin (left column) is absent from normal and diseased corneas. {alpha}2 integrin staining is positive in normal corneal epithelial cells and is either unchanged in PBK/ABK corneas (not shown) or decreased (middle column). Annexin II (A II) is present in normal epithelium and keratocytes and shows some increase in epithelial staining in some PBK/ABK corneas (right column). E, epithelium; S, stroma; SEF, subepithelial fibrosis. Immunofluorescent staining. Bar = 40 µm.

Subunits of the TN-C-binding integrins {alpha}8 and ß6 were absent in normal corneas, both in the central part (Fig 2, upper row) and the limbus (not shown). Only {alpha}9 integrin, in accordance with previous data in mice (Stepp et al. 1995 ; Stepp and Zhu 1997 ), was observed in normal limbal basal epithelial cells and, in some cases, in the most peripheral corneal basal cells (not shown). However, all these integrins appeared in the central epithelium of PBK/ABK corneas (Fig 2, lower row; Table 1). Ten of 17 PBK/ABK cases (59%) were positive for {alpha}8 integrin, 11/17 (65%) were positive for {alpha}9, and 12/15 (80%) were positive for ß6. All these integrins were mostly expressed in basal epithelial cells, whereas stromal keratocytes and endothelial cells were negative (Fig 2). The expression of these integrins was heterogeneous. Some PBK/ABK cases showed small local areas of positive staining, whereas in other cases the staining for these integrins was observed throughout large parts of the basal epithelium up to a whole cornea. The induction of these integrins was next correlated with the subepithelial expression of TN-C. For {alpha}8 integrin, such correlation was found in 8/17 cases (47%), for {alpha}9 in 9/17 cases (53%), and for ß6 in 11/15 cases (73%).



View larger version (86K):
[in this window]
[in a new window]
 
Figure 2. Appearance of TN-C integrin receptors in PBK/ABK corneas. Note the absence of {alpha}8, {alpha}9, and ß6 integrins in normal corneas (N, upper row) and their presence in the epithelium of PBK/ABK corneas, mostly in the basal cells (lower row). E, epithelium; S, stroma. Immunofluorescent staining. Bar = 40 µm.


 
View this table:
[in this window]
[in a new window]
 
Table 1. ECM receptor alterations in PBK/ABK corneal epitheliuma

TN-C-binding ß6 integrin, the most increased in PBK/ABK corneal epithelium, also binds to fibronectin and vitronectin. In a separate set of experiments, we tested by double immunofluorescence on serial sections whether ß6 expression in these corneas correlated with the expression of either vitronectin or fibronectin or TN-C. The correlation was judged to be positive both in cases where the integrin and the ligand were present (the integrin, in the epithelium, and the ligand, in the subepithelial region and/or epithelial BM), and in cases where the integrin and the ligand were both absent. Double staining for fibronectin and ß6 integrin, and also for vitronectin and ß6 integrin, was done using pairs of mouse monoclonal antibodies together. This was possible because the patterns of the ligands and the receptor did not overlap. Fibronectin and vitronectin were normally present in keratocytes (fibronectin also in the epithelial BM) but not in the epithelial cells, whereas ß6 integrin could be found only in the epithelial cells.

The results showed that ß6 expression in PBK/ABK corneal epithelium correlated with the expression of subepithelial fibronectin in 8/21 cases. Correlation of ß6 with vitronectin expression was seen in 7/20 cases. The correlation of ß6 with TN-C expression was significantly higher than with fibronectin or vitronectin (p<0.0008) and was observed in 21/24 cases (three of these cases were negative for both ß6 and subepithelial TN-C) (Fig 3). These results suggested that ß6 integrin appeared coordinately with TN-C in PBK/ABK corneas.



View larger version (79K):
[in this window]
[in a new window]
 
Figure 3. Co-distribution of ß6 integrin with TN-C but not with fibronectin (FN) or vitronectin (VN) in PBK/ABK corneas. Representative serial sections are shown. Upper row, left: double staining for ß6 integrin and VN. VN is normally absent from the epithelial BM and does not appear there in PBK/ABK corneas even in areas positive for ß6 integrin (no co-distribution). Upper row, right: double staining for ß6 integrin and FN. FN is normally present in the epithelial BM, Descemet's membrane, and keratocytes. Here, FN is absent from corneal epithelial BM (it is only present in keratocytes) despite the appearance of epithelial ß6 integrin in the same area (no co-distribution). Lower row: double staining of one section serial to those in the upper row for TN-C (left, polyclonal antibody) and ß6 integrin (right). TN-C is normally absent from adult central cornea. Here, abundant TN-C is revealed under the epithelial cells that express ß6 integrin (co-distribution). E, epithelium; S, stroma. Immunofluorescent staining. Bar = 40 µm.

We have previously shown that PBK/ABK corneas also displayed a decreased and discontinuous staining of the epithelial BM for fibronectin, Type IV collagen, laminin, and nidogen-1/entactin (Ljubimov et al. 1996 ). Therefore, in control experiments we analyzed the distribution of respective integrin receptors for these components in normal and diseased corneas. The distribution of {alpha}5ß1 (fibronectin receptor), {alpha}6ß4 (laminin receptor), and {alpha}3ß1 (collagen/laminin/entactin receptor) did not change in PBK/ABK epithelium (Table 1). {alpha}1ß1 (collagen receptor) was not found in any of the central corneas (not shown). These results suggest that epithelial cell integrin changes in PBK/ABK may reflect the abnormal presence of TN-C rather than alterations of major epithelial BM components or nonspecific corneal damage during storage and handling.

Increased Expression of ß6 Integrin mRNA in PBK/ABK Corneas
Semiquantitative RT-PCR from total corneal RNA demonstrated that normal corneas had relatively low levels of ß6 integrin mRNA that significantly increased in PBK/ABK corneas (Fig 4). The average increase of ß6 integrin mRNA expression in PBK/ABK vs normal corneas was approximately twofold and statistically significant (p<0.008). No correlation was found between ß6 integrin mRNA levels and the degree of visual acuity loss in PBK/ABK corneas examined before corneal transplantation.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 4. Semiquantitative RT-PCR analysis of ß6 integrin gene expression in normal and PBK/ABK corneas. Lanes 1–5, normal corneas; Lanes 6–17, PBK/ABK corneas. Note increased expression of ß6 integrin gene in PBK/ABK corneas. Samples were normalized with respect to ß2-microglobulin (ß2-MG) cDNA amplification. Autoradiographs of Southern blots are shown. -RT, negative control without the reverse transcription step.


  Discussion
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Tenascins form a family of five related large, hexameric ECM glycoproteins with modular structure. They play a role in various cell functions, including adhesion, migration, differentiation, and proliferation. In the extracellular space, tenascins can bind a plethora of other ECM molecules. Tenascins also bind to the surface of many cell types using several defined receptors, most of them belonging to the integrin family (reviewed in Orend and Chiquet-Ehrismann 2000 ; Jones and Jones 2000 ). Although prominent in developing embryos, tenascins become rather scarce in the adult state. However, they (especially TN-C) are often upregulated during wound healing and in disease conditions, including tissue fibrosis and cancer (Crossin 1996 ; Vollmer 1997 ).

TN-C is fairly abundant in normal central fetal corneas (Maseruka et al. 2000 ). In contrast, adult corneas retain it only in the peripheral limbus area (Tervo et al. 1990 ; Ljubimov et al. 1996 ), and the central cornea expresses TN-X only in the stroma (Tuori et al. 1999 ). However, in scarred, inflamed, and diseased corneas, TN-C becomes expressed again (Ljubimov et al. 1996 , Ljubimov et al. 1998a , Ljubimov et al. 1998b ; Zhou et al. 1996 ; Kenney et al. 1997 ; Maseruka et al. 1997 ; Tuori et al. 1997 ; Matsuda et al. 1999a ). It is most abundant in corneas with a common edematous disorder, PBK/ABK (Ljubimov et al. 1996 , Ljubimov et al. 1998a ).

We hypothesized that abnormal expression of TN-C in PBK/ABK corneas might be accompanied by altered expression of some of its binding proteins. A systematic study of these proteins in normal and PBK/ABK corneas was conducted. We found some TN-C receptors in both normal and PBK/ABK corneas, including {alpha}2ß1 integrin and annexin II. These receptors showed abnormal staining in about half of diseased corneas. The {alpha}2ß1 integrin is also a laminin/collagen receptor and was usually decreased in PBK/ABK epithelium. This might be due to laminin and/or collagen alterations seen in the epithelial BM of PBK/ABK corneas (Ljubimov et al. 1996 ). Our first account of the annexin II distribution pattern in human cornea completely agrees with findings recently described for rat cornea (Matsuda et al. 1999b ). These authors concluded that annexin II co-distributed with TN-C only in the limbus or during wound healing. In about half of PBK/ABK corneas, the epithelial staining for annexin II was either somewhat stronger compared to normal corneas (Fig 1) or somewhat weaker, with no difference in the stroma. Because of such changes, rather inconsistent with common upregulation of TN-C in PBK/ABK corneas, {alpha}2ß1 integrin and annexin II were not further studied.

Three TN-C-binding epithelial integrins, {alpha}8ß1, {alpha}9ß1, and {alpha}Vß6, did show correlation with TN-C expression. All of them, like TN-C, were only found in PBK/ABK central corneas. The corneal {alpha}9ß1 integrin has been thoroughly studied by Stepp's group (Stepp et al. 1995 ; Stepp and Zhu 1997 ; Sta Iglesia et al. 2000 ). We previously showed elevated expression of the ß6 integrin in PBK/ABK corneas by gene array analysis (Spirin et al. 1999 ) and are now confirming this result using other methods. We also provide the first description of the {alpha}8ß1 integrin distribution in normal and PBK/ABK human corneas, which was largely similar to that of {alpha}Vß6 integrin.

The {alpha}8ß1 integrin can serve as an RGD-dependent receptor for TN-C, fibronectin, vitronectin, and osteopontin (Schnapp et al. 1995b ; Varnum-Finney et al. 1995 ; Denda et al. 1998a , Denda et al. 1998b ). It is expressed on myofibroblasts that contribute to fibrotic response to injury (Levine et al. 2000 ) and mediates interactions of embryonic chick motor and sensory neurons with TN-C (Varnum-Finney et al. 1995 ). However, in vitro, {alpha}8ß1 could only bind to TN-C fragments but not to total protein (Denda et al. 1998a ). The importance of this integrin for kidney morphogenesis, as revealed in knockout mice (Muller et al. 1997 ), is apparently due to its interaction with osteopontin (Denda et al. 1998b ) but not with TN-C.

The {alpha}9ß1 integrin is expressed in epithelial, muscle, and neutrophil cells and binds to vascular cell adhesion molecule 1 (VCAM-1), TN-C, osteopontin, transglutaminase, and other ligands (Yokosaki et al. 1994 ; Smith et al. 1996 ; Taooka et al. 1999 ; Marcinkiewicz et al. 2000 ; Takahashi et al. 2000 ). It appears to be required for normal development of the lymphatic system (Huang et al. 2000 ). In neutrophils and activated endothelium, VCAM-1 seems to be the major ligand for {alpha}9ß1 integrin (Taooka et al. 1999 ). In the epithelial cells, {alpha}9ß1 integrin may interact with TN-C. These two proteins co-distribute during oral mucosa wound healing and in proliferative disorders (Hakkinen et al. 1999 , Hakkinen et al. 2000 ), and during healing of injured nasal mucosa (Yoshimura et al. 1999 ). In the cornea, {alpha}9ß1 integrin is confined to the limbal basal epithelium (Stepp et al. 1995 ) but appears, together with TN-C, during restratification after wound healing of central corneal epithelium (Stepp and Zhu 1997 ). Surprisingly, {alpha}9ß1 integrin is also induced in the central corneal epithelium after wound healing in TN-C knockout mice (Sta Iglesia et al. 2000 ). These data show that caution should be exerted in inferring interactions of proteins on the basis of their spatial and/or temporal co-distribution.

The {alpha}Vß6 is an epithelial integrin and can bind TN-C, fibronectin, and vitronectin (Busk et al. 1992 ; Prieto et al. 1993 ; Breuss et al. 1995 ; Huang et al. 1998 ). Many epithelia express this integrin only in the developing embryo but not in the adult state (Breuss et al. 1995 ). It can be re-expressed during inflammation, tissue repair after injury, tumor growth, at late stages of wound healing, and in fibrotic diseases (Breuss et al. 1995 ; Weinacker et al. 1995 ; Clark et al. 1996 ; Haapasalmi et al. 1996 ; Cass et al. 1998 ; Spirin et al. 1999 ; Hakkinen et al. 2000 ; Kaminski et al. 2000 ; Miller et al. 2001 ). This integrin is not necessary for wound healing, as shown using ß6 knockout mice (Huang et al. 1996 ). However, it plays a role as a downregulator of inflammation and may be involved in tissue fibrosis (Munger et al. 1999 ). Several growth factors, including transforming growth factor (TGF)-ß induce the expression of {alpha}Vß6 integrin (Sheppard et al. 1992 ). In turn, this integrin can bind and activate the latent form of TGF-ß1 (Munger et al. 1999 ).

As we showed here, {alpha}Vß6 integrin was absent from normal corneal epithelium but became expressed in most PBK/ABK corneas. Increased mRNA levels accompanied its appearance in diseased corneas. An important finding was that {alpha}Vß6 integrin expression specifically correlated with the deposition of subepithelial TN-C. At the protein level, such a correlation was also observed at late stages of oral mucosal healing (Hakkinen et al. 2000 ) and in lung fibrosis at the mRNA level (Kaminski et al. 2000 ). On the basis of the available data, we can speculate that {alpha}Vß6 integrin may be first expressed in PBK/ABK corneal epithelium as a result of epithelial alterations including edema, remodeling, and proliferation. This may activate corneal TGF-ß which, in turn, could induce the expression of subepithelial TN-C as part of the fibrotic process typical for this corneal disorder. Alternatively, TN-C may be upregulated by IGF-I elevated in PBK/ABK corneas (Saghizadeh et al. 2001 ; and our unpublished data), which could contribute to the {alpha}Vß6 integrin appearance in the epithelium.

TN-C is associated with inflammation and wound healing in remodeling and pathological tissues (Crossin 1996 ; Maseruka et al. 1997 ; Ljubimov et al. 1998a ; Jones and Jones 2000 ). Using knockout mice, it was shown that TN-C is not needed for corneal epithelial wound healing (Sta Iglesia et al. 2000 ). In the absence of TN-C, {alpha}9ß1 integrin is still induced during corneal wound healing, suggesting that it binds to a different ligand (Sta Iglesia et al. 2000 ). It would indeed be interesting to study {alpha}Vß6 in TN-C knockout mice, but mouse-reacting antibodies to this integrin that would stain tissue or work in Western blotting are not available.

At the same time, TN-C knockout mice have abnormal wound healing in corneal stroma (Mackie and Tucker 1999 ; Matsuda et al. 1999c ). Incidentally, TN-C deposits are also found primarily in the stroma of PBK/ABK corneas. However, these corneas do not appear to have an ongoing wound healing. During wound healing, disruptions of normal tissue architecture are repaired (Clark 1996 ). However, chronically edematous (because of fluid accumulation) PBK/ABK corneas usually do not display such disruptions and the integrity of the epithelial, stromal, or endothelial layer in these corneas may be compromised only in rare severe cases with rupture of bullae. Although PBK/ABK corneas have a fibrotic accumulation of certain ECM components, including TN-C, no typical scar tissue is formed and only scattered stromal myofibroblasts can be found (Ljubimov et al. 1996 ; Kenney et al. 2001 ). Interestingly, we did not observe any changes in the patterns of TN-C receptors in the PBK/ABK corneal stroma. It is possible either that these changes are quantitative and impossible to document by qualitative immunofluorescence or that stromal keratocytes use as yet unidentified receptors to TN-C. Further studies are needed to clarify these issues.

In summary, PBK/ABK corneas show abnormal upregulation of several TN-C-binding epithelial integrins, including {alpha}Vß6. The epithelial expression of this integrin spatially correlates with that of subepithelial TN-C (but not fibronectin or vitronectin) in diseased corneas and may be part of and/or contribute to the fibrotic process going on in PBK/ABK corneas.


  Footnotes

Presented in part at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, May 1998.


  Acknowledgments

Supported by grants from the NIH (EY10836 to MCK), the Braille Transcribers Guild (AVL), the Discovery Fund for Eye Research, and the Skirball Program for Molecular Ophthalmology (AVL, MCK).

We thank Drs Anthony Nesburn, Ezra Maguen, Ronald Gaster, Wayne Bowman, John Hofbauer, Theodore Perl, and Ira Wong for providing us with bullous keratopathy corneas, and the National Disease Research Interchange for supplying normal human corneas. We are grateful to Drs Mary Ann Stepp (George Washington University Medical Center; Washington, DC) and Luciano Zardi (Istituto Nazionale per la Ricerca sul Cancro; Genoa, Italy) for donating antibodies.

Received for publication March 6, 2001; accepted June 4, 2001.


  Literature Cited
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Balza E, Siri A, Ponassi M, Caocci F, Linnala A, Virtanen I, Zardi L (1993) Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin. FEBS Lett 332:39-43[Medline]

Breuss J, Gallo J, DeLisser H, Klimanskaya I, Folkesson H, Pittet J, Nishimura S, Aldape K, Landers D, Carpenter W, Gillett N, Sheppard D, Matthay M, Albelda S, Kramer R, Pytela R (1995) Expression of the ß6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 108:2241-2251[Abstract/Free Full Text]

Busk M, Pytela R, Sheppard D (1992) Characterization of the integrin {alpha}vß6 as a fibronectin-binding protein. J Biol Chem 267:5790-5796[Abstract/Free Full Text]

Cass DL, Bullard KM, Sylvester KG, Yang EY, Sheppard D, Herlyn M, Adzick NS (1998) Epidermal integrin expression is upregulated rapidly in human fetal wound repair. J Pediatr Surg 33:312-316[Medline]

Chung CY, Erickson HP (1994) Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol 126:539-548[Abstract]

Clark RAF (1996) Wound repair. Overview and general considerations. In Clark RAF, ed. The Molecular and Cellular Biology of Wound Repair. 2nd ed New York, Plenum Press, 3-50

Clark RAF, Ashcroft GS, Spencer MJ, Larjava H, Ferguson MW (1996) Re-epithelialization of normal human excisional wounds is associated with a switch from {alpha}vß5 to {alpha}vß6 integrins. Br J Dermatol 135:46-51[Medline]

Crossin KL (1996) Tenascin: a multifunctional extracellular matrix protein with a restricted distribution in development and disease. J Cell Biochem 61:592-598[Medline]

Denda S, Muller U, Crossin KL, Erickson HP, Reichardt LF (1998a) Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin {alpha}8ß1 receptor interactions with tenascin: murine {alpha}8ß1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C. Biochemistry 37:5464-5474[Medline]

Denda S, Reichardt LF, Muller U (1998b) Identification of osteopontin as a novel ligand for the integrin {alpha}8 ß1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell 9:1425-1435[Abstract/Free Full Text]

Dobbins KR, Price FW, Jr, Whitson WE (2000) Trends in the indications for penetrating keratoplasty in the midwestern United States. Cornea 19:813-816[Medline]

Haapasalmi K, Zhang K, Tonnesen M, Olerud J, Sheppard D, Salo T, Kramer R, Clark RAF, Uitto V-J, Larjava H (1996) Keratinocytes in human wounds express {alpha}vß6 integrin. J Invest Dermatol 106:42-48[Abstract]

Häkkinen L, Kainulainen T, Salo T, Grenman R, Larjava H (1999) Expression of integrin {alpha}9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma. Oral Dis 5:210-217[Medline]

Häkkinen L, Hildebrand HC, Berndt A, Kosmehl H, Larjava H (2000) Immunolocalization of tenascin-C, {alpha}9 integrin subunit, and {alpha}vß6 integrin during wound healing in human oral mucosa. J Histochem Cytochem 48:985-998[Abstract/Free Full Text]

Huang XZ, Wu JF, Cass D, Erle DJ, Corry D, Young SG, Farese RV, Jr, Sheppard D (1996) Inactivation of the integrin ß6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J Cell Biol 133:921-928[Abstract]

Huang XZ, Wu JF, Ferrando R, Lee JH, Wang YL, Farese RV, Jr, Sheppard D (2000) Fatal bilateral chylothorax in mice lacking the integrin {alpha}9ß1. Mol Cell Biol 20:5208-5215[Abstract/Free Full Text]

Huang X, Wu J, Spong S, Sheppard D (1998) The integrin {alpha}vß6 is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin. J Cell Sci 111:2189-2195[Abstract/Free Full Text]

Joester A, Faissner A (1999) Evidence for combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system. J Biol Chem 274:17144-17151[Abstract/Free Full Text]

Jones FS, Jones PL (2000) The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 218:235-259[Medline]

Joshi P, Chung CY, Aukhil I, Erickson HP (1993) Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. J Cell Sci 106:389-400[Abstract/Free Full Text]

Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, Huang X, Sheppard D, Heller RA (2000) Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA 97:1778-1783[Abstract/Free Full Text]

Kay EP, Cheung C-C, Jester JV, Nimni ME, Smith RE (1982) Type I collagen and fibronectin synthesis by retrocorneal fibrous membrane. Invest Ophthalmol Vis Sci 22:200-212[Abstract]

Kenney MC, Chwa M (1990) Abnormal extracellular matrix in corneas with pseudophakic bullous keratopathy. Cornea 9:115-121[Medline]

Kenney MC, Chwa M, Lin B, Huang G-H, Ljubimov AV, Brown DJ (2001) Identification of cell types in human diseased corneas. Cornea 20:309-316[Medline]

Kenney MC, Nesburn AB, Burgeson RE, Butkowski RJ, Ljubimov AV (1997) Abnormalities of the extracellular matrix in keratoconus corneas. Cornea 16:345-351[Medline]

Leprini A, Querze G, Zardi L (1994) Tenascin isoforms: possible targets for diagnosis and therapy of cancer and mechanisms regulating their expression. Perspect Dev Neurobiol 2:117-123[Medline]

Levine D, Rockey DC, Milner TA, Breuss JM, Fallon JT, Schnapp LM (2000) Expression of the integrin {alpha}8ß1 during pulmonary and hepatic fibrosis. Am J Pathol 156:1927-1935[Abstract/Free Full Text]

Liu GJ, Okisaka S, Mizukawa A, Momose A (1993) Histopathological study of pseudophakic bullous keratopathy developing after anterior chamber of iris-supported intraocular lens implantation. Jpn J Ophthalmol 37:414-425[Medline]

Ljubimov AV, Alba SA, Burgeson RE, Ninomiya Y, Sado Y, Sun T-T, Nesburn AB, Kenney MC, Maguen E (1998a) Extracellular matrix changes in human corneas after radial keratotomy. Exp Eye Res 67:265-272[Medline]

Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Wu RR, Ninomiya Y, Sado Y, Maguen E, Nesburn AB, Kenney MC (1996) Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci 37:997-1007[Abstract]

Ljubimov AV, Burgeson RE, Butkowski RJ, Michael AF, Sun T-T, Kenney MC (1995) Human corneal basement membrane heterogeneity: Topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest 72:461-473[Medline]

Ljubimov AV, Saghizadeh M, Spirin KS, Khin HL, Lewin SL, Zardi L, Bourdon MA, Kenney MC (1998b) Expression of tenascin-C splice variants in normal and bullous keratopathy human corneas. Invest Ophthalmol Vis Sci 39:1135-1142[Abstract]

Ljubimov AV, Saghizadeh M, Spirin KS, Mecham RP, Sakai LY, Kenney MC (1998c) Increased expression of fibrillin-1 in human corneas with bullous keratopathy. Cornea 17:309-314[Medline]

Mackie EJ (1997) Molecules in focus: tenascin-C. Int J Biochem Cell Biol 29:1133-1137[Medline]

Mackie EJ, Tucker RP (1999) The tenascin-C knockout revisited. J Cell Sci 112:3847-3853[Abstract/Free Full Text]

Maeno A, Naor J, Lee HM, Hunter WS, Rootman DS (2000) Three decades of corneal transplantation: indications and patient characteristics. Cornea 19:7-11[Medline]

Marcinkiewicz C, Taooka Y, Yokosaki Y, Calvete JJ, Marcinkiewicz MM, Lobb RR, Niewiarowski S, Sheppard D (2000) Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin {alpha}9ß1 with VCAM-1, tenascin-C, and osteopontin. J Biol Chem 275:31930-31937[Abstract/Free Full Text]

Maseruka H, Bonshek RE, Tullo AB (1997) Tenascin-C expression in normal, inflamed, and scarred human corneas. Br J Ophthalmol 81:677-682[Abstract/Free Full Text]

Maseruka H, Ridgway A, Tullo A, Bonshek R (2000) Developmental changes in patterns of expression of tenascin-C variants in the human cornea. Invest Ophthalmol Vis Sci 41:4101-4107[Abstract/Free Full Text]

Matsuda A, Tagawa Y, Matsuda H (1999a) TGF-ß2, tenascin, and integrin ß1 expression in superior limbic keratoconjunctivitis. Jpn J Ophthalmol 43:251-256[Medline]

Matsuda A, Tagawa Y, Yamamoto K, Matsuda H, Kusakabe M (1999b) Identification and immunohistochemical localization of annexin II in rat cornea. Curr Eye Res 19:368-375[Medline]

Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M (1999c) Corneal wound healing in tenascin knockout mouse. Invest Ophthalmol Vis Sci 40:1071-1080[Abstract]

McCartney MD, Robertson DP, Wood TO, McLaughlin BJ (1987) ATPase pump site density in human dysfunctional corneal endothelium. Invest Ophthalmol Vis Sci 28:1955-1962[Abstract]

Meiners S, Geller HM (1997) Long and short splice variants of human tenascin differentially regulate neurite outgrowth. Mol Cell Neurosci 10:100-116

Meiners S, Mercado ML, Nur-e-Kamal MS, Geller HM (1999) Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance. Neuroscience 19:8443-8453[Medline]

Miller LA, Barnett NL, Sheppard D, Hyde DM (2001) Expression of the ß6 integrin subunit is associated with sites of neutrophil influx in lung epithelium. J Histochem Cytochem 49:41-48[Abstract/Free Full Text]

Muller U, Wang D, Denda S, Meneses JJ, Pedersen RA, Reichardt LF (1997) Integrin {alpha}8ß1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 88:603-613[Medline]

Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D (1999) The integrin {alpha}vß6 binds and activates latent TGF ß1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319-328[Medline]

Murphy–Ullrich JE, Lightner VA, Aukhil I, Yan YZ, Erickson HP, Hook M (1991) Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol 115:1127-1136[Abstract]

Numa A, Nakamura J, Takashima M, Kani K (1993) Long-term corneal endothelial changes after intraocular lens implantation. Anterior vs. posterior chamber lenses. Jpn J Ophthalmol 37:78-87[Medline]

Orend G, Chiquet–Ehrismann R (2000) Adhesion modulation by antiadhesive molecules of the extracellular matrix. Exp Cell Res 261:104-110[Medline]

Palmer EL, Ruegg C, Ferrando R, Pytela R, Sheppard D (1993) Sequence and tissue distribution of the integrin {alpha}9 subunit, a novel partner of ß1 that is widely distributed in epithelia and muscle. J Cell Biol 123:1289-1297[Abstract]

Patel NP, Kim T, Rapuano CJ, Cohen EJ, Laibson PR (2000) Indications for and outcomes of repeat penetrating keratoplasty, 1989-1995. Ophthalmology 107:719-724[Medline]

Prieto AL, Edelman GM, Crossin KL (1993) Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc Natl Acad Sci USA 90:10154-10158[Abstract]

Saghizadeh M, Khin HL, Bourdon MA, Kenney MC, Ljubimov AV (1998) Novel splice variants of human tenascin-C mRNA identified in normal and bullous keratopathy corneas. Cornea 17:326-332[Medline]

Saghizadeh M, Chwa M, Aoki A, Lin B, Pirouzmanesh A, Brown DJ, Ljubimov AV, Kenney MC (2001) Altered expression of growth factors and cytokines in keratoconus, bullous keratopathy and diabetic corneas. Exp Eye Res 73:179-189[Medline]

Sasaki Y, Tuberville AW, Wood TO, McLaughlin BJ (1986) Freeze fracture study of human corneal endothelial dysfunction. Invest Ophthalmol Vis Sci 27:480-485[Abstract]

Schnapp LM, Breuss JM, Ramos DM, Sheppard D, Pytela R (1995a) Sequence and tissue distribution of the human integrin {alpha}8 subunit: a ß1-associated {alpha} subunit expressed in smooth muscle cells. J Cell Sci 108:537-544[Abstract/Free Full Text]

Schnapp LM, Hatch N, Ramos DM, Klimanskaya IV, Sheppard D, Pytela R (1995b) The human integrin {alpha}8ß1 functions as a receptor for tenascin, fibronectin, and vitronectin. J Biol Chem 270:23196-23202[Abstract/Free Full Text]

Sheppard D, Cohen DS, Wang A, Busk M (1992) Transforming growth factor ß differentially regulates expression of integrin subunits in guinea pig airway epithelial cells. J Biol Chem 267:17409-17414[Abstract/Free Full Text]

Smith LL, Cheung HK, Ling LE, Chen J, Sheppard D, Pytela R, Giachelli CM (1996) Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by {alpha}9ß1 integrin. J Biol Chem 271:28485-28491[Abstract/Free Full Text]

Spirin KS, Ljubimov AV, Castellon R, Wiedoeft O, Marano M, Sheppard D, Kenney MC, Brown DJ (1999) Analysis of gene expression in human bullous keratopathy corneas containing limiting amounts of RNA. Invest Ophthalmol Vis Sci 40:3108-3115[Abstract/Free Full Text]

Sriramarao P, Mendler M, Bourdon MA (1993) Endothelial cell attachment and spreading on human tenascin is mediated by {alpha}2ß1 and {alpha}Vß3 integrins. J Cell Sci 105:1001-1012[Abstract/Free Full Text]

Sta Iglesia DD, Gala PH, Qiu T, Stepp MA (2000) Integrin expression during epithelial migration and restratification in the tenascin-C-deficient mouse cornea. J Histochem Cytochem 48:363-375[Abstract/Free Full Text]

Stepp MA, Zhu L (1997) Upregulation of {alpha}9 integrin and tenascin during epithelial regeneration after debridement in the cornea. J Histochem Cytochem 45:189-201[Abstract/Free Full Text]

Stepp MA, Zhu L, Sheppard D, Cranfill R (1995) Localized distribution of {alpha}9 integrin in the cornea and changes in expression during corneal epithelial cell differentiation. J Histochem Cytochem 43:353-362[Abstract/Free Full Text]

Takahashi H, Isobe T, Horibe S, Takagi J, Yokosaki Y, Sheppard D, Saito Y (2000) Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins {alpha}9ß1 and {alpha}4ß1. J Biol Chem 275:23589-23595[Abstract/Free Full Text]

Taooka Y, Chen J, Yednock T, Sheppard D (1999) The integrin {alpha}9ß1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol 145:413-420[Abstract/Free Full Text]

Tervo K, Tervo T, van Setten G-B, Virtanen I (1991) Integrins in human corneal epithelium. Cornea 10:461-465[Medline]

Tervo T, van Setten GB, Lehto I, Tervo K, Tarkkanen A, Virtanen I (1990) Immunohistochemical demonstration of tenascin in the normal human limbus with special reference to trabeculectomy. Ophthal Res 22:128-133

Tuori A, Uusitalo H, Thornell LE, Yoshida T, Virtanen I (1999) The expression of tenascin-X in developing and adult rat and human eye. Histochem J 31:245-252[Medline]

Tuori A, Virtanen I, Aine E, Uusitalo H (1997) The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea. Graefes Arch Clin Exp Ophthalmol 235:222-229[Medline]

Varnum-Finney B, Venstrom K, Muller U, Kypta R, Backus C, Chiquet M, Reichardt LF (1995) The integrin receptor {alpha}8ß1 mediates interactions of embryonic chick motor and sensory neurons with tenascin-C. Neuron 14:1213-1222[Medline]

Vollmer G (1997) Biologic and oncologic implications of tenascin-C/hexabrachion proteins. Crit Rev Oncol Hematol 25:187-210[Medline]

Waring GO (1982) Posterior collagenous layer of the cornea: ultrastructural classification of abnormal collagenous tissue posterior to Descemet's membrane in 30 cases. Arch Ophthalmol 100:122-134[Abstract]

Weinacker A, Chen A, Agrez M, Cone RI, Nishimura S, Wayner E, Pytela R, Sheppard D (1994) Role of the integrin {alpha}vß6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J Biol Chem 269:6940-6948[Abstract/Free Full Text]

Weinacker A, Ferrando R, Elliott M, Hogg J, Balmes J, Sheppard D (1995) Distribution of integrins {alpha}vß6 and {alpha}9ß1 and their known ligands, fibronectin and tenascin, in human airways. Am J Respir Cell Mol Biol 12:547-556[Abstract]

Yokosaki Y, Monis H, Chen J, Sheppard D (1996) Differential effects of the integrins {alpha}9ß1, {alpha}vß3, and {alpha}vß6 on cell proliferative responses to tenascin. Roles of the ß subunit extracellular and cytoplasmic domains. J Biol Chem 27:24144-24150

Yokosaki Y, Palmer EL, Prieto AL, Crossin KL, Bourdon MA, Pytela R, Sheppard D (1994) The integrin {alpha}9ß1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin. J Biol Chem 269:26691-26696[Abstract/Free Full Text]

Yoshimura E, Majima A, Sakakura Y, Sakakura T, Yoshida T (1999) Expression of tenascin-C and the integrin {alpha}9 subunit in regeneration of rat nasal mucosa after chemical injury: involvement in migration and proliferation of epithelial cells. Histochem Cell Biol 111:259-264[Medline]

Zhou L, Yue BY, Twining SS, Sugar J, Feder RS (1996) Expression of wound healing and stress-related proteins in keratoconus corneas. Curr Eye Res 15:1124-1131[Medline]